Aging Population
The fund invests more than 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.
Trend Stats
1-Month Return
+2.92%
3-Month Return
+9.99%
12-Month Return
+13.75%
Volatility Score
1.0
RSI
51.5
ST Trend
Neutral
LT Trend
Up
Short-Term Trend
Neutral
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Aging Population
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co | $1T | +59.05% | +2.29% | +3.17% | 3.1 | Down | Up |
| JNJ | Johnson&Johnson | $663B | +57.73% | +21.22% | +8.50% | 1.9 | Up | Up |
| ABBV | AbbVie | $453B | +24.40% | +14.82% | +5.19% | 2.1 | Neutral | Up |
| MRK | Merck | $371B | +83.40% | +25.90% | +17.45% | 2.8 | Up | Up |
| AZN | ASTRAZENECA | $252B | +1.28% | -9.91% | +5.25% | 1.9 | Down | Down |
| AMGN | Amgen | $236B | +58.43% | +27.25% | +12.76% | 2.1 | Up | Up |
| WELL | Welltower REIT | $170B | +42.80% | +18.03% | +2.37% | 1.9 | Down | Up |
| BMY | Bristol-MyersSqu | $136B | +48.55% | +19.39% | +1.41% | 2.1 | Up | Up |
| MDT | Medtronic | $120B | +4.66% | +15.98% | +9.25% | 2.3 | Up | Up |
| SYK | Stryker | $116B | -21.95% | +0.91% | -9.77% | 3.0 | Down | Down |
| REGN | Regeneron Pharma | $85B | +45.10% | +31.80% | +8.94% | 2.4 | Up | Up |
| BSX | Boston Scientifi | $69B | -55.42% | -2.15% | -2.63% | 3.6 | Neutral | Down |
| EW | Edwards Lifescns | $52B | +11.07% | +2.80% | +0.33% | 2.1 | Neutral | Up |
| VTR | Ventas REIT | $46B | +36.33% | +14.79% | -0.64% | 2.1 | Down | Up |
| ONC | BeOne Medi Sp ADR | $41B | +4.82% | +27.98% | +10.91% | 2.7 | Up | Up |
| DXCM | Dexcom | $33B | +9.18% | +21.09% | +1.10% | 2.7 | Up | Up |
| INCY | Incyte | $26B | +46.30% | +25.20% | +5.10% | 2.5 | Up | Up |
| UTHR | United Therapeut | $21B | +21.74% | -10.97% | -5.99% | 2.9 | Down | Down |
| ZBH | Zimmer Biomet Hldgs | $19B | -6.27% | +13.43% | +2.36% | 2.6 | Up | Up |
| NBIX | Neurocrine Biosc | $16B | +8.01% | -7.00% | -6.27% | 2.6 | Down | Up |
| EXEL | Exelixis | $15B | +55.78% | +12.42% | +5.37% | 2.6 | Up | Up |
| OHI | Omega Hlth REIT | $14B | +14.03% | +7.65% | -4.84% | 1.7 | Down | Neutral |
| HALO | Halozyme Therape | $13B | +47.06% | +53.90% | +32.39% | 3.2 | Up | Up |
| DVA | DaVita | $12B | +33.45% | -4.26% | -19.30% | 2.5 | Down | Up |
| GKOS | Glaukos | $10B | +88.92% | +45.84% | +4.07% | 3.4 | Up | Up |
| PODD | Insulet | $10B | -57.67% | +0.73% | -11.59% | 3.6 | Down | Down |
| ENSG | Ensign Group | $10B | -1.70% | +4.00% | -3.03% | 2.2 | Down | Down |
| CGON | CG ONCOLOGY | $6.6B | +125.79% | +33.13% | +4.58% | 3.8 | Neutral | Up |
| TFX | Teleflex | $5.9B | +7.04% | +4.99% | -1.01% | 3.0 | Neutral | Up |
| MMSI | Merit Med Sys | $5.4B | -3.62% | +42.13% | +4.40% | 2.1 | Up | Up |
| SBRA | Sabra HC REIT | $5.3B | +15.99% | +19.38% | +2.10% | 2.0 | Neutral | Up |
| ACAD | Acadia Pharma | $4.8B | +10.93% | +29.01% | +3.20% | 3.2 | Neutral | Up |
| LIVN | LivaNova | $4.5B | +41.31% | +11.12% | -3.99% | 2.8 | Neutral | Up |
| ITGR | Integer Holdings | $4.3B | +18.29% | +36.40% | +1.16% | 0.3 | Up | Up |
| NHI | Natl Health REIT | $3.5B | -5.25% | +4.99% | -4.94% | 2.1 | Down | Down |
| NHC | National Healthc | $3.4B | +93.50% | +16.66% | +5.01% | 3.4 | Down | Up |
| BKD | Brookdale Sr Liv | $2.8B | +53.06% | -1.01% | -17.29% | 4.3 | Down | Down |
| LTC | LTC Prop REIT | $2.2B | +19.61% | +19.93% | +7.60% | 2.0 | Up | Up |
| NVCR | NovoCure NPV | $2.1B | +46.09% | -0.28% | +10.26% | 4.4 | Up | Up |
| AGIO | Agios Pharm | $2B | -8.08% | +14.97% | +4.75% | 3.8 | Down | Up |
| 0 | 0 | 0 | 0 | Bullish | Bullish |